Author:
Wulf Markus,Hoehn Petra,Trinder Peter
Reference4 articles.
1. Bull, M., Lee, D., Stucky, J., Chiu, Y. -L., Rubin, A., Horton, H., and McElrath, M. J. (2007) Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322, 57–69.
2. Maecker, H. T., Moon, J., Bhatia, S., Ghanekar, S. M., Maino, V. C., Payne, J. K., Kuus-Reichel, K., Chang, J. C., Summers, A., Clay, T. M., Morse, M. A.,Lyerly, H. K., De La Rosa, C., Ankerst, D. P., and Disis, M. L. (2005) Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol. 6, 17–30.
3. Janetzki, S., Panageas, K. S., Ben-Porat, L., Boyer, J., Britten, C. M., Clay, T. M., Kalos, M., Maecker, H. T., Romero, P., Yuan, J., Kast, W. M., and Hoos, A. (2008) Results and harmonization of guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol. Immunother. 57, 303–315.
4. Janetzki, S., Cox, J. H., Oden, N., and Ferrari, G. (2006) Standardization and validation issues of the ELISPOT assay. Methods Mol. Biol. 302, 51–86.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献